DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

Medivation, Inc. (NASDAQ: MDVN)



company name or ticker

Brean Capital Reiterates Buy Rating, Raises PT On Medivation As Xtandi Deserves To Move Upstream

Jeff Cooper: Biotech and the Dollar Blink

The reversals in biotech and the US dollar are worth watching.

Best One-Drug Wonder Stock for 2015

You've got to start somewhere. Here's our top picks of biotechs with just one drug on the market.

Trade-Ideas: Medivation (MDVN) Is Today's New Lifetime High Stock

Zacks Industry Outlook Highlights: Orexigen, MannKind, Amgen, Medivation and Express Scripts - Press

Zacks Industry Outlook Highlights: Orexigen, MannKind, Amgen, Medivation and Express Scripts - Press Releases

Medigene AG: Addressing The CAR-T Market Pain Points

Wedbush Securities Reiterates Outperform, Raises PT On Medivation On Increased International Estimat

Wedbush Securities Reiterates Outperform, Raises PT On Medivation On Increased International Estimates

Johnson & Johnson Might Have The Last Laugh Over AbbVie Winning Pharmacyclics

Insider Insider Buys And Sells: Twitter, Graham Holdings

Insider Buying in Energy Ramps Up as Market Continues Higher

See More Articles...